Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04031755 · ClinicalTrials.gov registry record · Phase 1
A Proof-of-Concept Study of Minocycline in Autism
A Phase 1 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
NCT04031755 is a Phase 1 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 53 participants.
The verdict
NCT04031755, a Phase 1 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if Minocycline shows initial evidence of efficacy, safety, and tolerability in youth with Autism Spectrum Disorder ages 12 to 22 years.
Interventions
- DRUG Placebos
- DRUG Minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2019-04-19 |
| Est. Completion | 2020-10-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04031755
The ClinicalTrials.gov registry entry for NCT04031755 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT04031755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04031755 about?
NCT04031755 is a clinical study titled "A Proof-of-Concept Study of Minocycline in Autism". The purpose of the study is to determine if Minocycline shows initial evidence of efficacy, safety, and tolerability in youth with Autism Spectrum Disorder ages 12 to 22 years.
What is the current status of trial NCT04031755?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2019-04-19. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT04031755?
The interventions under investigation include: Placebos (DRUG), Minocycline (DRUG).
Who is sponsoring clinical trial NCT04031755?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.